Based on the conservative Bonferroni-adjusted threshold for significance, T-tau/Aβ1–42 ratio, T-tau, and P-tau were significantly elevated in AD compared with each of the other neurodegenerative disorders tested, except PNFA. This evidence concerns the gene MAPT and Alzheimer disease.